Success Metrics

Completion Rate
0%(0/2)
Active Trials
1(33%)
Terminated
2(67%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_1
2
67%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(2)

Detailed Status

Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (66.7%)
N/A1 (33.3%)

Trials by Status

recruiting133%
terminated267%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_1

Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

NCT01608516
terminatedphase_1

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

NCT02666547
terminatednot_applicable

Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET

NCT03809689

Clinical Trials (3)

Showing 3 of 3 trials
NCT01608516Phase 1

Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

Recruiting
NCT02666547Phase 1

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Terminated
NCT03809689Not Applicable

Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET

Terminated

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3